

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of mast cell degranulation (GO:0043306) | 7.83910829 |
| 2 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 7.83910829 |
| 3 | positive regulation of mast cell activation (GO:0033005) | 7.41239295 |
| 4 | leukocyte aggregation (GO:0070486) | 6.93197407 |
| 5 | cellular extravasation (GO:0045123) | 6.44936234 |
| 6 | leukocyte migration involved in inflammatory response (GO:0002523) | 6.32320530 |
| 7 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 6.26323875 |
| 8 | regulation of mast cell degranulation (GO:0043304) | 6.07136300 |
| 9 | positive regulation of leukocyte degranulation (GO:0043302) | 6.04281100 |
| 10 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.87464349 |
| 11 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.81135160 |
| 12 | regulation of mast cell activation involved in immune response (GO:0033006) | 5.77539842 |
| 13 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 5.50741213 |
| 14 | regulation of leukocyte degranulation (GO:0043300) | 5.43183987 |
| 15 | regulation of hypersensitivity (GO:0002883) | 5.41410141 |
| 16 | neutrophil activation involved in immune response (GO:0002283) | 5.34583157 |
| 17 | regulation of mast cell activation (GO:0033003) | 5.30990204 |
| 18 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.29546929 |
| 19 | detection of bacterium (GO:0016045) | 5.25639077 |
| 20 | angiotensin maturation (GO:0002003) | 5.19105876 |
| 21 | response to fungus (GO:0009620) | 5.17524188 |
| 22 | respiratory burst (GO:0045730) | 5.14948877 |
| 23 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.11724881 |
| 24 | defense response to fungus (GO:0050832) | 4.96946491 |
| 25 | response to peptidoglycan (GO:0032494) | 4.69019919 |
| 26 | positive regulation of megakaryocyte differentiation (GO:0045654) | 4.68817163 |
| 27 | detection of external biotic stimulus (GO:0098581) | 4.63481811 |
| 28 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.63007439 |
| 29 | actin nucleation (GO:0045010) | 4.55995907 |
| 30 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.52970608 |
| 31 | * leukotriene metabolic process (GO:0006691) | 4.50781015 |
| 32 | * production of molecular mediator involved in inflammatory response (GO:0002532) | 4.50285592 |
| 33 | regulation of regulated secretory pathway (GO:1903305) | 4.47247646 |
| 34 | positive regulation of regulated secretory pathway (GO:1903307) | 4.39380313 |
| 35 | detection of molecule of bacterial origin (GO:0032490) | 4.38937109 |
| 36 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.38684481 |
| 37 | negative regulation of interleukin-12 production (GO:0032695) | 4.31961917 |
| 38 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.29465986 |
| 39 | thrombin receptor signaling pathway (GO:0070493) | 4.27505157 |
| 40 | * leukotriene biosynthetic process (GO:0019370) | 4.24480031 |
| 41 | regulation of gamma-delta T cell activation (GO:0046643) | 4.24095174 |
| 42 | tyrosine phosphorylation of STAT protein (GO:0007260) | 4.12358203 |
| 43 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.09309116 |
| 44 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.09309116 |
| 45 | modulation by symbiont of host immune response (GO:0052553) | 4.09309116 |
| 46 | positive regulation by symbiont of host defense response (GO:0052509) | 4.09309116 |
| 47 | modulation by symbiont of host defense response (GO:0052031) | 4.09309116 |
| 48 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.09309116 |
| 49 | detection of biotic stimulus (GO:0009595) | 4.05868877 |
| 50 | positive regulation of hematopoietic progenitor cell differentiation (GO:1901534) | 4.04829520 |
| 51 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.02560603 |
| 52 | negative regulation of granulocyte differentiation (GO:0030853) | 4.02503205 |
| 53 | sequestering of metal ion (GO:0051238) | 3.98900201 |
| 54 | negative regulation of phagocytosis (GO:0050765) | 3.98743137 |
| 55 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.96408481 |
| 56 | microglial cell activation (GO:0001774) | 3.91686353 |
| 57 | neutrophil mediated immunity (GO:0002446) | 3.85466634 |
| 58 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.79079516 |
| 59 | neutrophil activation (GO:0042119) | 3.76694703 |
| 60 | mannose metabolic process (GO:0006013) | 3.76365534 |
| 61 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.75242741 |
| 62 | negative regulation of cell killing (GO:0031342) | 3.75242741 |
| 63 | macrophage activation (GO:0042116) | 3.74736393 |
| 64 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.64283696 |
| 65 | neutrophil chemotaxis (GO:0030593) | 3.60378463 |
| 66 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.57944614 |
| 67 | immunoglobulin mediated immune response (GO:0016064) | 3.49872142 |
| 68 | neutrophil migration (GO:1990266) | 3.49702184 |
| 69 | B cell mediated immunity (GO:0019724) | 3.49582600 |
| 70 | granulocyte activation (GO:0036230) | 3.47711512 |
| 71 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.47647267 |
| 72 | leukocyte cell-cell adhesion (GO:0007159) | 3.45051304 |
| 73 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.44752141 |
| 74 | response to host immune response (GO:0052572) | 3.44752141 |
| 75 | regulation of acute inflammatory response to antigenic stimulus (GO:0002864) | 3.44689015 |
| 76 | * lipoxygenase pathway (GO:0019372) | 3.42862976 |
| 77 | response to interleukin-15 (GO:0070672) | 3.42099862 |
| 78 | type I interferon signaling pathway (GO:0060337) | 3.40877396 |
| 79 | cellular response to type I interferon (GO:0071357) | 3.40877396 |
| 80 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.39894604 |
| 81 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.39577940 |
| 82 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.38920492 |
| 83 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.38920492 |
| 84 | response to type I interferon (GO:0034340) | 3.38346460 |
| 85 | positive regulation of B cell differentiation (GO:0045579) | 3.38327577 |
| 86 | germinal center formation (GO:0002467) | 3.35623305 |
| 87 | response to muramyl dipeptide (GO:0032495) | 3.35005075 |
| 88 | defense response to protozoan (GO:0042832) | 3.33941946 |
| 89 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.32283450 |
| 90 | negative regulation of T cell mediated immunity (GO:0002710) | 3.32190328 |
| 91 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 3.31802704 |
| 92 | megakaryocyte development (GO:0035855) | 3.31041277 |
| 93 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 3.30558164 |
| 94 | activated T cell proliferation (GO:0050798) | 3.28070359 |
| 95 | positive thymic T cell selection (GO:0045059) | 3.27498130 |
| 96 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.27472978 |
| 97 | leukocyte degranulation (GO:0043299) | 3.26207622 |
| 98 | myeloid cell activation involved in immune response (GO:0002275) | 3.25743367 |
| 99 | regulation of antigen processing and presentation (GO:0002577) | 3.24581547 |
| 100 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.21245513 |
| 101 | regulation of B cell differentiation (GO:0045577) | 3.19391723 |
| 102 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.18505990 |
| 103 | response to host (GO:0075136) | 3.18505990 |
| 104 | response to host defenses (GO:0052200) | 3.18505990 |
| 105 | regulation of T cell tolerance induction (GO:0002664) | 3.17946458 |
| 106 | positive regulation of chemokine secretion (GO:0090197) | 3.17832842 |
| 107 | regulation of tolerance induction (GO:0002643) | 3.17028186 |
| 108 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.16606893 |
| 109 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.14973264 |
| 110 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.13646130 |
| 111 | macrophage differentiation (GO:0030225) | 3.09670324 |
| 112 | granulocyte chemotaxis (GO:0071621) | 3.09055837 |
| 113 | positive regulation of interferon-alpha production (GO:0032727) | 3.08926461 |
| 114 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.05910528 |
| 115 | granulocyte migration (GO:0097530) | 3.05749911 |
| 116 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.04486785 |
| 117 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.04180894 |
| 118 | cellular response to interleukin-15 (GO:0071350) | 3.03429745 |
| 119 | superoxide anion generation (GO:0042554) | 3.00794044 |
| 120 | detection of other organism (GO:0098543) | 3.00787149 |
| 121 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.99575187 |
| 122 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.99575187 |
| 123 | mast cell activation (GO:0045576) | 2.99517867 |
| 124 | actin filament polymerization (GO:0030041) | 2.92866113 |
| 125 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.92855310 |
| 126 | regulation of phagocytosis (GO:0050764) | 2.92709816 |
| 127 | response to protozoan (GO:0001562) | 2.92556430 |
| 128 | negative thymic T cell selection (GO:0045060) | 2.91881902 |
| 129 | positive regulation of antigen processing and presentation (GO:0002579) | 2.91881215 |
| 130 | * icosanoid biosynthetic process (GO:0046456) | 2.91513013 |
| 131 | * fatty acid derivative biosynthetic process (GO:1901570) | 2.91513013 |
| 132 | negative regulation of innate immune response (GO:0045824) | 2.91230949 |
| 133 | regulation of apoptotic cell clearance (GO:2000425) | 2.89733482 |
| 134 | negative regulation of interleukin-6 production (GO:0032715) | 2.89525190 |
| 135 | myeloid leukocyte activation (GO:0002274) | 2.88902584 |
| 136 | positive regulation of acute inflammatory response (GO:0002675) | 2.88071406 |
| 137 | regulation of interferon-alpha production (GO:0032647) | 2.87183546 |
| 138 | positive regulation of macrophage differentiation (GO:0045651) | 2.86685148 |
| 139 | macrophage activation involved in immune response (GO:0002281) | 2.85894174 |
| 140 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.81375460 |
| 141 | dendritic cell migration (GO:0036336) | 2.78707978 |
| 142 | B cell receptor signaling pathway (GO:0050853) | 2.77797945 |
| 143 | citrulline biosynthetic process (GO:0019240) | 2.77282517 |
| 144 | reactive oxygen species biosynthetic process (GO:1903409) | 2.76439754 |
| 145 | granulocyte differentiation (GO:0030851) | 2.74982708 |
| 146 | mast cell activation involved in immune response (GO:0002279) | 2.73888485 |
| 147 | mast cell degranulation (GO:0043303) | 2.73888485 |
| 148 | cytokine metabolic process (GO:0042107) | 2.73751319 |
| 149 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.73050165 |
| 150 | myeloid leukocyte mediated immunity (GO:0002444) | 2.72523137 |
| 151 | integrin-mediated signaling pathway (GO:0007229) | 2.70445596 |
| 152 | leukocyte mediated cytotoxicity (GO:0001909) | 2.68246339 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 9.09766378 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.25077600 |
| 3 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 4.05852257 |
| 4 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.73417833 |
| 5 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.70444459 |
| 6 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.56935398 |
| 7 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.44743704 |
| 8 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.43414632 |
| 9 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.13472622 |
| 10 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.06558726 |
| 11 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.89753349 |
| 12 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.81994858 |
| 13 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.71159560 |
| 14 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.67308484 |
| 15 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.60848612 |
| 16 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.51063682 |
| 17 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.45418510 |
| 18 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.44117961 |
| 19 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.39796194 |
| 20 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.37036228 |
| 21 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.15132903 |
| 22 | * SPI1_23127762_ChIP-Seq_K562_Human | 2.14949480 |
| 23 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.08681514 |
| 24 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.06726428 |
| 25 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.06654335 |
| 26 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 2.01356490 |
| 27 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 2.00249704 |
| 28 | MAF_26560356_Chip-Seq_TH1_Human | 2.00193571 |
| 29 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.98417098 |
| 30 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.95303635 |
| 31 | MYB_26560356_Chip-Seq_TH2_Human | 1.86051027 |
| 32 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.82410142 |
| 33 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.72785838 |
| 34 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.71449181 |
| 35 | UTX_26944678_Chip-Seq_JUKART_Human | 1.70195259 |
| 36 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.70036888 |
| 37 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.69854787 |
| 38 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.64952418 |
| 39 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.64503146 |
| 40 | MYC_22102868_ChIP-Seq_BL_Human | 1.62493611 |
| 41 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.61938174 |
| 42 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.61244411 |
| 43 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.55101347 |
| 44 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.55096566 |
| 45 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.52869599 |
| 46 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.51885414 |
| 47 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.50505722 |
| 48 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.50258840 |
| 49 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.49365741 |
| 50 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.45904981 |
| 51 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.45443415 |
| 52 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.44792176 |
| 53 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.43428609 |
| 54 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.42898418 |
| 55 | MYB_26560356_Chip-Seq_TH1_Human | 1.42736235 |
| 56 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.42274225 |
| 57 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.40550977 |
| 58 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.39414181 |
| 59 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.37633425 |
| 60 | GATA1_19941826_ChIP-Seq_K562_Human | 1.37059847 |
| 61 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.33720722 |
| 62 | GATA1_22025678_ChIP-Seq_K562_Human | 1.33302316 |
| 63 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.33014574 |
| 64 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.32307132 |
| 65 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.31089374 |
| 66 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.29500657 |
| 67 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.28647783 |
| 68 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.28450893 |
| 69 | GATA2_19941826_ChIP-Seq_K562_Human | 1.25620526 |
| 70 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.22503621 |
| 71 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.22045166 |
| 72 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.17683717 |
| 73 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.16303674 |
| 74 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.14345092 |
| 75 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.13279145 |
| 76 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.11774050 |
| 77 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.11224046 |
| 78 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.10997144 |
| 79 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.09367777 |
| 80 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.08135093 |
| 81 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.08068336 |
| 82 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.07800826 |
| 83 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.07697574 |
| 84 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.07371697 |
| 85 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.06565572 |
| 86 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.06452701 |
| 87 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.05961829 |
| 88 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05621551 |
| 89 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.05402519 |
| 90 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.03062968 |
| 91 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.02758411 |
| 92 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.00816375 |
| 93 | MAF_26560356_Chip-Seq_TH2_Human | 0.99857384 |
| 94 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.99666178 |
| 95 | GATA3_26560356_Chip-Seq_TH2_Human | 0.95266428 |
| 96 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.91896244 |
| 97 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.91864877 |
| 98 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.89778977 |
| 99 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.87585871 |
| 100 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.87299230 |
| 101 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87222665 |
| 102 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.87132153 |
| 103 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.86902304 |
| 104 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.84144669 |
| 105 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.81013292 |
| 106 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.80207621 |
| 107 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.79170242 |
| 108 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.79000506 |
| 109 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.78829023 |
| 110 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.75727612 |
| 111 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.75119302 |
| 112 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.74113762 |
| 113 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.72011967 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003436_decreased_susceptibility_to | 4.71602526 |
| 2 | MP0003303_peritoneal_inflammation | 4.00491940 |
| 3 | MP0002148_abnormal_hypersensitivity_rea | 3.56384902 |
| 4 | * MP0002419_abnormal_innate_immunity | 3.25111707 |
| 5 | MP0005464_abnormal_platelet_physiology | 3.04465082 |
| 6 | MP0000465_gastrointestinal_hemorrhage | 2.92477415 |
| 7 | MP0004510_myositis | 2.84649338 |
| 8 | MP0005025_abnormal_response_to | 2.80073395 |
| 9 | MP0009278_abnormal_bone_marrow | 2.71265523 |
| 10 | MP0009785_altered_susceptibility_to | 2.69908299 |
| 11 | MP0001533_abnormal_skeleton_physiology | 2.69746524 |
| 12 | * MP0005000_abnormal_immune_tolerance | 2.66081373 |
| 13 | MP0005058_abnormal_lysosome_morphology | 2.58562718 |
| 14 | MP0001835_abnormal_antigen_presentation | 2.49400052 |
| 15 | MP0001800_abnormal_humoral_immune | 2.38040149 |
| 16 | MP0002452_abnormal_antigen_presenting | 2.36107547 |
| 17 | MP0002405_respiratory_system_inflammati | 2.33818363 |
| 18 | MP0003300_gastrointestinal_ulcer | 2.28970803 |
| 19 | * MP0002420_abnormal_adaptive_immunity | 2.25110326 |
| 20 | * MP0001819_abnormal_immune_cell | 2.24410307 |
| 21 | * MP0001790_abnormal_immune_system | 2.21213599 |
| 22 | * MP0005387_immune_system_phenotype | 2.21213599 |
| 23 | MP0003724_increased_susceptibility_to | 2.20826398 |
| 24 | MP0000343_altered_response_to | 2.17952306 |
| 25 | MP0002723_abnormal_immune_serum | 2.12178213 |
| 26 | MP0003566_abnormal_cell_adhesion | 2.11682157 |
| 27 | MP0003763_abnormal_thymus_physiology | 2.06060010 |
| 28 | MP0001851_eye_inflammation | 2.00557201 |
| 29 | MP0008260_abnormal_autophagy | 1.96602248 |
| 30 | MP0004808_abnormal_hematopoietic_stem | 1.96201332 |
| 31 | MP0003183_abnormal_peptide_metabolism | 1.90841600 |
| 32 | MP0000685_abnormal_immune_system | 1.90819507 |
| 33 | MP0003172_abnormal_lysosome_physiology | 1.86515561 |
| 34 | MP0004947_skin_inflammation | 1.83750403 |
| 35 | MP0005671_abnormal_response_to | 1.82913045 |
| 36 | MP0002877_abnormal_melanocyte_morpholog | 1.82608240 |
| 37 | MP0001853_heart_inflammation | 1.79415896 |
| 38 | MP0006082_CNS_inflammation | 1.76703457 |
| 39 | MP0002398_abnormal_bone_marrow | 1.76445867 |
| 40 | * MP0001845_abnormal_inflammatory_respons | 1.74307153 |
| 41 | MP0001545_abnormal_hematopoietic_system | 1.67414344 |
| 42 | MP0005397_hematopoietic_system_phenotyp | 1.67414344 |
| 43 | MP0000716_abnormal_immune_system | 1.67327152 |
| 44 | MP0003075_altered_response_to | 1.63915555 |
| 45 | MP0002132_abnormal_respiratory_system | 1.60173101 |
| 46 | MP0010155_abnormal_intestine_physiology | 1.59515204 |
| 47 | MP0002837_dystrophic_cardiac_calcinosis | 1.55095980 |
| 48 | MP0003191_abnormal_cellular_cholesterol | 1.54624090 |
| 49 | MP0009840_abnormal_foam_cell | 1.47565742 |
| 50 | MP0005451_abnormal_body_composition | 1.44474321 |
| 51 | MP0002933_joint_inflammation | 1.43731626 |
| 52 | MP0009333_abnormal_splenocyte_physiolog | 1.43659641 |
| 53 | MP0002429_abnormal_blood_cell | 1.42855000 |
| 54 | * MP0002722_abnormal_immune_system | 1.41291522 |
| 55 | MP0003448_altered_tumor_morphology | 1.40229082 |
| 56 | MP0008469_abnormal_protein_level | 1.39504849 |
| 57 | MP0005310_abnormal_salivary_gland | 1.37670182 |
| 58 | MP0002396_abnormal_hematopoietic_system | 1.36871731 |
| 59 | MP0001986_abnormal_taste_sensitivity | 1.34591043 |
| 60 | MP0003638_abnormal_response/metabolism_ | 1.32909833 |
| 61 | MP0005390_skeleton_phenotype | 1.32896369 |
| 62 | * MP0000689_abnormal_spleen_morphology | 1.31218232 |
| 63 | MP0003828_pulmonary_edema | 1.29798000 |
| 64 | MP0005076_abnormal_cell_differentiation | 1.29317166 |
| 65 | MP0000490_abnormal_crypts_of | 1.28274826 |
| 66 | MP0004883_abnormal_blood_vessel | 1.28068562 |
| 67 | MP0009764_decreased_sensitivity_to | 1.25180178 |
| 68 | MP0000858_altered_metastatic_potential | 1.24257425 |
| 69 | MP0005023_abnormal_wound_healing | 1.21743237 |
| 70 | MP0002138_abnormal_hepatobiliary_system | 1.21582236 |
| 71 | MP0004381_abnormal_hair_follicle | 1.20213605 |
| 72 | MP0001873_stomach_inflammation | 1.17831486 |
| 73 | MP0005174_abnormal_tail_pigmentation | 1.11114639 |
| 74 | MP0003690_abnormal_glial_cell | 1.10885939 |
| 75 | MP0005166_decreased_susceptibility_to | 1.10232793 |
| 76 | MP0009763_increased_sensitivity_to | 1.07918694 |
| 77 | MP0010307_abnormal_tumor_latency | 1.01748830 |
| 78 | MP0009765_abnormal_xenobiotic_induced | 1.00887573 |
| 79 | MP0008004_abnormal_stomach_pH | 1.00649901 |
| 80 | MP0000249_abnormal_blood_vessel | 0.96397986 |
| 81 | MP0003656_abnormal_erythrocyte_physiolo | 0.94681816 |
| 82 | MP0000604_amyloidosis | 0.93687675 |
| 83 | MP0005164_abnormal_response_to | 0.91922640 |
| 84 | MP0003866_abnormal_defecation | 0.87550283 |
| 85 | MP0002998_abnormal_bone_remodeling | 0.87297869 |
| 86 | MP0000920_abnormal_myelination | 0.86910755 |
| 87 | MP0003279_aneurysm | 0.86713994 |
| 88 | MP0003453_abnormal_keratinocyte_physiol | 0.86515563 |
| 89 | MP0003045_fibrosis | 0.80072204 |
| 90 | MP0008873_increased_physiological_sensi | 0.79910772 |
| 91 | MP0005075_abnormal_melanosome_morpholog | 0.77436632 |
| 92 | MP0000703_abnormal_thymus_morphology | 0.75987164 |
| 93 | MP0002277_abnormal_respiratory_mucosa | 0.74770281 |
| 94 | MP0001663_abnormal_digestive_system | 0.74590027 |
| 95 | MP0010352_gastrointestinal_tract_polyps | 0.73562759 |
| 96 | MP0003705_abnormal_hypodermis_morpholog | 0.72708413 |
| 97 | MP0003806_abnormal_nucleotide_metabolis | 0.72701985 |
| 98 | MP0000767_abnormal_smooth_muscle | 0.70181590 |
| 99 | * MP0003795_abnormal_bone_structure | 0.68605324 |
| 100 | MP0000015_abnormal_ear_pigmentation | 0.67900783 |
| 101 | MP0002166_altered_tumor_susceptibility | 0.66676953 |
| 102 | MP0001915_intracranial_hemorrhage | 0.65294856 |
| 103 | MP0002006_tumorigenesis | 0.63682154 |
| 104 | MP0001958_emphysema | 0.59078240 |
| 105 | MP0003329_amyloid_beta_deposits | 0.58477112 |
| 106 | MP0000733_abnormal_muscle_development | 0.57296676 |
| 107 | MP0002133_abnormal_respiratory_system | 0.56055537 |
| 108 | MP0005388_respiratory_system_phenotype | 0.56055537 |
| 109 | MP0003221_abnormal_cardiomyocyte_apopto | 0.54257139 |
| 110 | MP0009931_abnormal_skin_appearance | 0.52128731 |
| 111 | MP0005167_abnormal_blood-brain_barrier | 0.51705756 |
| 112 | MP0001216_abnormal_epidermal_layer | 0.50679818 |
| 113 | MP0008874_decreased_physiological_sensi | 0.48436258 |
| 114 | MP0005319_abnormal_enzyme/_coenzyme | 0.48383126 |
| 115 | MP0008438_abnormal_cutaneous_collagen | 0.48320674 |
| 116 | MP0003091_abnormal_cell_migration | 0.47564959 |
| 117 | MP0002332_abnormal_exercise_endurance | 0.47328397 |
| 118 | MP0002693_abnormal_pancreas_physiology | 0.46962372 |
| 119 | MP0000609_abnormal_liver_physiology | 0.46550435 |
| 120 | MP0002009_preneoplasia | 0.45316841 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 7.86057841 |
| 2 | Eczematoid dermatitis (HP:0000976) | 7.09914347 |
| 3 | Recurrent gram-negative bacterial infections (HP:0005420) | 6.82861659 |
| 4 | Recurrent bacterial skin infections (HP:0005406) | 6.73092127 |
| 5 | Petechiae (HP:0000967) | 6.39686643 |
| 6 | Systemic lupus erythematosus (HP:0002725) | 5.42625157 |
| 7 | Prolonged bleeding time (HP:0003010) | 4.68027183 |
| 8 | Abnormal platelet volume (HP:0011876) | 4.62038776 |
| 9 | Purpura (HP:0000979) | 4.60715308 |
| 10 | Abnormality of macrophages (HP:0004311) | 4.58039146 |
| 11 | Menorrhagia (HP:0000132) | 4.37689231 |
| 12 | Increased mean platelet volume (HP:0011877) | 4.36680058 |
| 13 | Chronic obstructive pulmonary disease (HP:0006510) | 4.22181588 |
| 14 | Obstructive lung disease (HP:0006536) | 4.22181588 |
| 15 | Gingivitis (HP:0000230) | 4.02133362 |
| 16 | Recurrent skin infections (HP:0001581) | 4.01987349 |
| 17 | Gingival bleeding (HP:0000225) | 3.99601586 |
| 18 | Mediastinal lymphadenopathy (HP:0100721) | 3.98102139 |
| 19 | Recurrent fungal infections (HP:0002841) | 3.91310652 |
| 20 | Gastrointestinal infarctions (HP:0005244) | 3.89324862 |
| 21 | Cellulitis (HP:0100658) | 3.86221762 |
| 22 | Vacuolated lymphocytes (HP:0001922) | 3.84502541 |
| 23 | Impaired platelet aggregation (HP:0003540) | 3.75884377 |
| 24 | Abnormal platelet function (HP:0011869) | 3.75884377 |
| 25 | Encephalitis (HP:0002383) | 3.53747022 |
| 26 | Keratoconjunctivitis sicca (HP:0001097) | 3.49177544 |
| 27 | Urticaria (HP:0001025) | 3.39169018 |
| 28 | Dysostosis multiplex (HP:0000943) | 3.28854017 |
| 29 | Increased cerebral lipofuscin (HP:0011813) | 3.21346608 |
| 30 | Keratoconjunctivitis (HP:0001096) | 3.20393527 |
| 31 | Glomerulonephritis (HP:0000099) | 3.14884599 |
| 32 | Epistaxis (HP:0000421) | 3.12910946 |
| 33 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.09359095 |
| 34 | Hypochromic microcytic anemia (HP:0004840) | 3.08788190 |
| 35 | Pulmonary infiltrates (HP:0002113) | 3.01298479 |
| 36 | Agammaglobulinemia (HP:0004432) | 2.98846273 |
| 37 | Hemoptysis (HP:0002105) | 2.97253954 |
| 38 | Myositis (HP:0100614) | 2.96788523 |
| 39 | Spontaneous hematomas (HP:0007420) | 2.94761342 |
| 40 | Akinesia (HP:0002304) | 2.94537320 |
| 41 | Episodic fever (HP:0001954) | 2.83385308 |
| 42 | Panhypogammaglobulinemia (HP:0003139) | 2.81940321 |
| 43 | IgM deficiency (HP:0002850) | 2.79247794 |
| 44 | Hypochromic anemia (HP:0001931) | 2.78683265 |
| 45 | Stomatitis (HP:0010280) | 2.77844074 |
| 46 | Mucopolysacchariduria (HP:0008155) | 2.74388340 |
| 47 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.74388340 |
| 48 | T lymphocytopenia (HP:0005403) | 2.68148915 |
| 49 | Recurrent viral infections (HP:0004429) | 2.65830631 |
| 50 | Pustule (HP:0200039) | 2.63798344 |
| 51 | Periodontitis (HP:0000704) | 2.63270949 |
| 52 | Meningitis (HP:0001287) | 2.62639504 |
| 53 | Chronic otitis media (HP:0000389) | 2.60994563 |
| 54 | Gastrointestinal stroma tumor (HP:0100723) | 2.60906233 |
| 55 | Abnormality of complement system (HP:0005339) | 2.56973947 |
| 56 | Abnormality of T cell number (HP:0011839) | 2.56868974 |
| 57 | Lymphopenia (HP:0001888) | 2.55382949 |
| 58 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.54436402 |
| 59 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.54436402 |
| 60 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.54436402 |
| 61 | Pulmonary embolism (HP:0002204) | 2.54153021 |
| 62 | Anorexia (HP:0002039) | 2.52636913 |
| 63 | Interstitial pulmonary disease (HP:0006530) | 2.50888157 |
| 64 | Orchitis (HP:0100796) | 2.49036577 |
| 65 | Amyloidosis (HP:0011034) | 2.44813451 |
| 66 | Papilledema (HP:0001085) | 2.43590124 |
| 67 | Abnormality of T cells (HP:0002843) | 2.40682923 |
| 68 | Thoracic kyphosis (HP:0002942) | 2.37125002 |
| 69 | Leukocytosis (HP:0001974) | 2.36663944 |
| 70 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.36393823 |
| 71 | Increased density of long bones (HP:0006392) | 2.33063478 |
| 72 | Abnormality of the pleura (HP:0002103) | 2.32417441 |
| 73 | Increased IgM level (HP:0003496) | 2.31845889 |
| 74 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.30411674 |
| 75 | Abnormality of glycolipid metabolism (HP:0010969) | 2.30411674 |
| 76 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.30411674 |
| 77 | J-shaped sella turcica (HP:0002680) | 2.30300187 |
| 78 | Recurrent bronchitis (HP:0002837) | 2.29311248 |
| 79 | Abnormality of the peritoneum (HP:0002585) | 2.28881785 |
| 80 | Abnormality of placental membranes (HP:0011409) | 2.28145553 |
| 81 | Amniotic constriction ring (HP:0009775) | 2.28145553 |
| 82 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.27766270 |
| 83 | Recurrent sinusitis (HP:0011108) | 2.26412145 |
| 84 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.26102210 |
| 85 | Osteolytic defects of the hand bones (HP:0009699) | 2.26102210 |
| 86 | Abnormality of the lumbar spine (HP:0100712) | 2.25445557 |
| 87 | Recurrent cutaneous fungal infections (HP:0011370) | 2.23353276 |
| 88 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.23353276 |
| 89 | Granulocytopenia (HP:0001913) | 2.23066745 |
| 90 | Inflammation of the large intestine (HP:0002037) | 2.20873748 |
| 91 | Premature loss of primary teeth (HP:0006323) | 2.20691348 |
| 92 | Hypergammaglobulinemia (HP:0010702) | 2.17466684 |
| 93 | Gangrene (HP:0100758) | 2.16853794 |
| 94 | Microcytic anemia (HP:0001935) | 2.15766351 |
| 95 | Abnormality of T cell physiology (HP:0011840) | 2.15758280 |
| 96 | Restrictive lung disease (HP:0002091) | 2.14071372 |
| 97 | Viral hepatitis (HP:0006562) | 2.12627471 |
| 98 | Recurrent lower respiratory tract infections (HP:0002783) | 2.12153548 |
| 99 | Spondylolisthesis (HP:0003302) | 2.10657150 |
| 100 | Verrucae (HP:0200043) | 2.07681278 |
| 101 | Papilloma (HP:0012740) | 2.07681278 |
| 102 | Fetal akinesia sequence (HP:0001989) | 2.05737067 |
| 103 | Optic neuritis (HP:0100653) | 2.05226762 |
| 104 | Retrobulbar optic neuritis (HP:0100654) | 2.05226762 |
| 105 | Cervical subluxation (HP:0003308) | 2.04779242 |
| 106 | Gastrointestinal inflammation (HP:0004386) | 2.04309721 |
| 107 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.03689886 |
| 108 | Arterial thrombosis (HP:0004420) | 2.02995523 |
| 109 | Slender build (HP:0001533) | 2.02399565 |
| 110 | Hematochezia (HP:0002573) | 2.02137163 |
| 111 | Increased serum ferritin (HP:0003281) | 2.00131123 |
| 112 | Thick nail (HP:0001805) | 1.99047293 |
| 113 | Osteomyelitis (HP:0002754) | 1.98698089 |
| 114 | Abnormality of the endocardium (HP:0004306) | 1.98438841 |
| 115 | Skin rash (HP:0000988) | 1.97575197 |
| 116 | Glomerulopathy (HP:0100820) | 1.97052922 |
| 117 | Popliteal pterygium (HP:0009756) | 1.96486723 |
| 118 | Hepatosplenomegaly (HP:0001433) | 1.96055119 |
| 119 | Loss of speech (HP:0002371) | 1.95583110 |
| 120 | Abnormality of the thoracic spine (HP:0100711) | 1.93079033 |
| 121 | Abnormality of iron homeostasis (HP:0011031) | 1.92422629 |
| 122 | Nephritis (HP:0000123) | 1.91183051 |
| 123 | Slow saccadic eye movements (HP:0000514) | 1.90777859 |
| 124 | Vertigo (HP:0002321) | 1.88037283 |
| 125 | Cerebral aneurysm (HP:0004944) | 1.87549952 |
| 126 | Colitis (HP:0002583) | 1.86373892 |
| 127 | Nasal polyposis (HP:0100582) | 1.84377217 |
| 128 | Complement deficiency (HP:0004431) | 1.84182265 |
| 129 | Peritonitis (HP:0002586) | 1.84020690 |
| 130 | Easy fatigability (HP:0003388) | 1.83594987 |
| 131 | Recurrent pneumonia (HP:0006532) | 1.82911616 |
| 132 | Vasculitis (HP:0002633) | 1.80437444 |
| 133 | Bruising susceptibility (HP:0000978) | 1.80277884 |
| 134 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.80121111 |
| 135 | Increased IgE level (HP:0003212) | 1.78938184 |
| 136 | Abnormality of the nasal mucosa (HP:0000433) | 1.77389770 |
| 137 | Sepsis (HP:0100806) | 1.76209035 |
| 138 | Chest pain (HP:0100749) | 1.75909420 |
| 139 | Axonal loss (HP:0003447) | 1.75762044 |
| 140 | Ulnar deviation of the wrist (HP:0003049) | 1.74467343 |
| 141 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.73675766 |
| 142 | Skin ulcer (HP:0200042) | 1.72592473 |
| 143 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.71328166 |
| 144 | Aplasia of the musculature (HP:0100854) | 1.70589255 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.05446576 |
| 2 | IRAK4 | 4.02879098 |
| 3 | BLK | 3.48749077 |
| 4 | EPHB1 | 3.36622900 |
| 5 | FES | 2.79574726 |
| 6 | RIPK4 | 2.78106170 |
| 7 | TRPM7 | 2.71519647 |
| 8 | KIT | 2.45754164 |
| 9 | STK10 | 2.34004811 |
| 10 | TRIB3 | 2.27368781 |
| 11 | TNK2 | 2.19746795 |
| 12 | BTK | 2.16416864 |
| 13 | CSK | 2.11009941 |
| 14 | TYK2 | 2.07263979 |
| 15 | EEF2K | 1.93778023 |
| 16 | FGR | 1.90049027 |
| 17 | ERN1 | 1.79404323 |
| 18 | HCK | 1.76468255 |
| 19 | TEC | 1.72258859 |
| 20 | CLK1 | 1.71891521 |
| 21 | TTN | 1.70639348 |
| 22 | TAOK1 | 1.69989471 |
| 23 | MATK | 1.64483605 |
| 24 | TGFBR2 | 1.57730101 |
| 25 | TAOK3 | 1.56959541 |
| 26 | PKN2 | 1.56666430 |
| 27 | TXK | 1.56058237 |
| 28 | ZAP70 | 1.54620225 |
| 29 | MAP3K13 | 1.49849566 |
| 30 | GRK6 | 1.38622225 |
| 31 | ITK | 1.38448308 |
| 32 | IRAK3 | 1.38028288 |
| 33 | LRRK2 | 1.36191354 |
| 34 | CAMK1D | 1.35695654 |
| 35 | MAP2K3 | 1.34283067 |
| 36 | SYK | 1.32900064 |
| 37 | MST1R | 1.29632552 |
| 38 | SIK3 | 1.27334931 |
| 39 | CAMK1G | 1.26757572 |
| 40 | TBK1 | 1.25119582 |
| 41 | MAP3K1 | 1.22882907 |
| 42 | DMPK | 1.22504778 |
| 43 | ERBB3 | 1.18323909 |
| 44 | CSF1R | 1.14765239 |
| 45 | YES1 | 1.14030571 |
| 46 | PTK6 | 1.13661511 |
| 47 | MAPKAPK5 | 1.13388131 |
| 48 | PIM2 | 1.11488470 |
| 49 | LYN | 1.07233124 |
| 50 | BMPR2 | 1.07000799 |
| 51 | MARK2 | 1.06140503 |
| 52 | IRAK2 | 1.01287101 |
| 53 | IRAK1 | 0.98491844 |
| 54 | CDK6 | 0.97588765 |
| 55 | PAK4 | 0.95437707 |
| 56 | BMX | 0.92726402 |
| 57 | PDK1 | 0.91337002 |
| 58 | LCK | 0.89355515 |
| 59 | MAP3K6 | 0.89263748 |
| 60 | JAK2 | 0.89093844 |
| 61 | PIK3CG | 0.88671115 |
| 62 | PIM1 | 0.88464994 |
| 63 | MAPKAPK3 | 0.87574957 |
| 64 | PTK2 | 0.87058571 |
| 65 | PRKD2 | 0.86920973 |
| 66 | TAOK2 | 0.85638347 |
| 67 | TESK2 | 0.83989560 |
| 68 | CDC42BPA | 0.80029436 |
| 69 | MAP3K14 | 0.77706462 |
| 70 | ALK | 0.74539566 |
| 71 | JAK1 | 0.73346900 |
| 72 | RPS6KA2 | 0.72867770 |
| 73 | MAPK12 | 0.72243367 |
| 74 | STK4 | 0.70769110 |
| 75 | MOS | 0.70475041 |
| 76 | CDK19 | 0.68094672 |
| 77 | PRKCQ | 0.68076086 |
| 78 | SMG1 | 0.67457571 |
| 79 | IKBKB | 0.67034922 |
| 80 | RPS6KA6 | 0.66603596 |
| 81 | KSR2 | 0.65592374 |
| 82 | MAP3K2 | 0.65551262 |
| 83 | RPS6KC1 | 0.64595388 |
| 84 | RPS6KL1 | 0.64595388 |
| 85 | SIK2 | 0.64111965 |
| 86 | MAP3K11 | 0.63974326 |
| 87 | MARK3 | 0.63668403 |
| 88 | MAP3K7 | 0.61519396 |
| 89 | STK24 | 0.60717269 |
| 90 | MAPK7 | 0.59456466 |
| 91 | KDR | 0.58016336 |
| 92 | CDK12 | 0.57351983 |
| 93 | FGFR3 | 0.56940924 |
| 94 | FGFR4 | 0.56426147 |
| 95 | JAK3 | 0.56345820 |
| 96 | MAPK4 | 0.55899010 |
| 97 | MAP2K4 | 0.54391108 |
| 98 | SIK1 | 0.53999459 |
| 99 | MAP3K5 | 0.52083193 |
| 100 | STK11 | 0.51660946 |
| 101 | HIPK2 | 0.51429589 |
| 102 | FYN | 0.49505400 |
| 103 | SGK3 | 0.49148726 |
| 104 | IKBKE | 0.47905532 |
| 105 | RPS6KB2 | 0.47451176 |
| 106 | PRKCH | 0.46377116 |
| 107 | DYRK1B | 0.45618008 |
| 108 | NEK9 | 0.45369176 |
| 109 | PRKCD | 0.44956600 |
| 110 | MAP3K3 | 0.44912579 |
| 111 | MAP2K6 | 0.44844749 |
| 112 | MAP3K8 | 0.43488825 |
| 113 | DAPK2 | 0.42861148 |
| 114 | RIPK1 | 0.42457339 |
| 115 | ROCK2 | 0.42159300 |
| 116 | ABL1 | 0.42046733 |
| 117 | EPHA3 | 0.41695253 |
| 118 | * MAPKAPK2 | 0.41230191 |
| 119 | RET | 0.40940357 |
| 120 | PRKG2 | 0.40723750 |
| 121 | PRPF4B | 0.40281607 |
| 122 | EGFR | 0.39122214 |
| 123 | MAP2K2 | 0.39075302 |
| 124 | GRK7 | 0.37845749 |
| 125 | NLK | 0.37820201 |
| 126 | MAP3K12 | 0.35563440 |
| 127 | TESK1 | 0.34730761 |
| 128 | RAF1 | 0.33542489 |
| 129 | LIMK1 | 0.33516996 |
| 130 | MAP3K10 | 0.33147885 |
| 131 | RPS6KA4 | 0.32810831 |
| 132 | CDK9 | 0.32575787 |
| 133 | SGK2 | 0.31324833 |
| 134 | CAMKK1 | 0.31185414 |
| 135 | IGF1R | 0.30440059 |
| 136 | SRC | 0.29572242 |
| 137 | MAP2K1 | 0.29317648 |
| 138 | PRKCZ | 0.29262741 |
| 139 | KSR1 | 0.28735190 |
| 140 | STK38 | 0.28572551 |
| 141 | PDPK1 | 0.28259995 |
| 142 | PTK2B | 0.28215157 |
| 143 | PRKD1 | 0.28154071 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 4.03104322 |
| 2 | Asthma_Homo sapiens_hsa05310 | 3.82753159 |
| 3 | Leishmaniasis_Homo sapiens_hsa05140 | 3.26867050 |
| 4 | Renin-angiotensin system_Homo sapiens_hsa04614 | 2.91267332 |
| 5 | Other glycan degradation_Homo sapiens_hsa00511 | 2.85892434 |
| 6 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 2.84956921 |
| 7 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.55716770 |
| 8 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.41065635 |
| 9 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 2.40844842 |
| 10 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.15947662 |
| 11 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.10206363 |
| 12 | Pertussis_Homo sapiens_hsa05133 | 2.08382353 |
| 13 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.06690885 |
| 14 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 2.03480689 |
| 15 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.03276165 |
| 16 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.99628985 |
| 17 | Platelet activation_Homo sapiens_hsa04611 | 1.97045121 |
| 18 | Tuberculosis_Homo sapiens_hsa05152 | 1.82490159 |
| 19 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.76223771 |
| 20 | Lysosome_Homo sapiens_hsa04142 | 1.64854546 |
| 21 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.60558966 |
| 22 | Shigellosis_Homo sapiens_hsa05131 | 1.58836562 |
| 23 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.53387068 |
| 24 | Phagosome_Homo sapiens_hsa04145 | 1.48084504 |
| 25 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.38284909 |
| 26 | Viral myocarditis_Homo sapiens_hsa05416 | 1.37687779 |
| 27 | Malaria_Homo sapiens_hsa05144 | 1.37131922 |
| 28 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.36749149 |
| 29 | Salmonella infection_Homo sapiens_hsa05132 | 1.35987385 |
| 30 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.35958845 |
| 31 | Legionellosis_Homo sapiens_hsa05134 | 1.32881297 |
| 32 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.29411966 |
| 33 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.28435974 |
| 34 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.28024215 |
| 35 | Apoptosis_Homo sapiens_hsa04210 | 1.27672029 |
| 36 | * Toxoplasmosis_Homo sapiens_hsa05145 | 1.26375823 |
| 37 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.24442722 |
| 38 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.23937394 |
| 39 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.23898610 |
| 40 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.19097293 |
| 41 | Amoebiasis_Homo sapiens_hsa05146 | 1.15085529 |
| 42 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.14050989 |
| 43 | Hepatitis B_Homo sapiens_hsa05161 | 1.11597166 |
| 44 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.10793498 |
| 45 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.10077658 |
| 46 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.09937536 |
| 47 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 1.08114171 |
| 48 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.05111489 |
| 49 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.02416798 |
| 50 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.01088719 |
| 51 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.00214855 |
| 52 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.98167740 |
| 53 | Measles_Homo sapiens_hsa05162 | 0.95567832 |
| 54 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.83727959 |
| 55 | Endocytosis_Homo sapiens_hsa04144 | 0.83717657 |
| 56 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.82562163 |
| 57 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.82006881 |
| 58 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.81453116 |
| 59 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.78893054 |
| 60 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.78529213 |
| 61 | Influenza A_Homo sapiens_hsa05164 | 0.76813631 |
| 62 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.71937648 |
| 63 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.70121496 |
| 64 | Focal adhesion_Homo sapiens_hsa04510 | 0.69788741 |
| 65 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.66807919 |
| 66 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.66540166 |
| 67 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.64792927 |
| 68 | Colorectal cancer_Homo sapiens_hsa05210 | 0.64743664 |
| 69 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.63802002 |
| 70 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.63664670 |
| 71 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.62925437 |
| 72 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.62646021 |
| 73 | Allograft rejection_Homo sapiens_hsa05330 | 0.61340621 |
| 74 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.59683284 |
| 75 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.59532147 |
| 76 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.58400669 |
| 77 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.57685372 |
| 78 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.57682005 |
| 79 | HTLV-I infection_Homo sapiens_hsa05166 | 0.54629301 |
| 80 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.54220348 |
| 81 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.53961094 |
| 82 | * Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.53659361 |
| 83 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.53404354 |
| 84 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.52698611 |
| 85 | Hepatitis C_Homo sapiens_hsa05160 | 0.51883690 |
| 86 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.51841495 |
| 87 | Endometrial cancer_Homo sapiens_hsa05213 | 0.50940748 |
| 88 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.49370999 |
| 89 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.48434729 |
| 90 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.48066797 |
| 91 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.46885199 |
| 92 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.45892703 |
| 93 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.44466808 |
| 94 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.44250084 |
| 95 | Prion diseases_Homo sapiens_hsa05020 | 0.43974925 |
| 96 | Insulin resistance_Homo sapiens_hsa04931 | 0.43670591 |
| 97 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.43525311 |
| 98 | Bladder cancer_Homo sapiens_hsa05219 | 0.41952172 |
| 99 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.41938036 |
| 100 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.41416587 |
| 101 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.41106267 |
| 102 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.41014427 |
| 103 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.40437109 |
| 104 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.39976461 |
| 105 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.39765293 |
| 106 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.39408011 |
| 107 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.38299724 |
| 108 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.38138311 |
| 109 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.37243328 |
| 110 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.35639207 |
| 111 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.35575242 |
| 112 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.35473094 |
| 113 | Pathways in cancer_Homo sapiens_hsa05200 | 0.35321456 |
| 114 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.35075420 |
| 115 | Glioma_Homo sapiens_hsa05214 | 0.34842558 |
| 116 | Adherens junction_Homo sapiens_hsa04520 | 0.34491565 |
| 117 | Prostate cancer_Homo sapiens_hsa05215 | 0.34301018 |
| 118 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.33670719 |
| 119 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.32117815 |
| 120 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.32003731 |
| 121 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.31153172 |
| 122 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.30809439 |
| 123 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.29726966 |
| 124 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.29655513 |
| 125 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.29470608 |

